Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2021-09-01
2022-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesized that both programs could decrease total, abdominal and visceral fat mass but due to differences in muscle solicitation, metabolism adaptation and blood flow, and that running could favors greater fat mass losses.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biking vs. Running: Comparison of EPOC, Substrate Oxidation, Appetite and Energy Intakes in Men With Overweight/Obesity.
NCT06082310
8-Weeks of High-Intensity Interval Training or Concurrent Training in Overweight and Obese Adult Males
NCT05351177
The Effectiveness and Safety of HIIT in Overweight Male Subjects
NCT05000437
Acute Effects of High-intensity Interval Aerobic and Functional Training at Different Intensities
NCT07180550
Home-Based HIT in Obese Individuals
NCT03557736
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
20 men with overweight or obesity should completed HIIT program three times a week during twelve weeks.
i) High intensity interval training - BIKE (HIIE BIKE) 10 cycles of speeding up for 45 s at 80-thPHR followed by pedaling slowly (40% thPHR) for 1m30s (37min30s) ii) High intensity interval training - RUN (HIIE RUN) 9 cycles of speeding up for 45 s at 80-thPHR followed by pedaling slowly (40% thPHR) for 1m30s (35min15s)
Body composition will be measured before and after HIIT program by Dual-energy X-ray absorptiometry (DXA).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High intensity interval training - BIKE (HIIE BIKE)
10 cycles of speeding up for 45 s at 80-thPHR followed by pedaling slowly (40% thPHR) for 1m30s (37min30s)
Physical activity
Comparison of HIIT mode (running vs cycling)
High intensity interval training - RUN (HIIE RUN)
9 cycles of speeding up for 45 s at 80-thPHR followed by pedaling slowly (40% thPHR) for 1m30s (35min15s)
Physical activity
Comparison of HIIT mode (running vs cycling)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Physical activity
Comparison of HIIT mode (running vs cycling)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with overweight or obesity (BMI \> 25 kg/m2 and ≤ 40 kg/m2)
Exclusion Criteria
* painful joints,
* taking ß-blocker
18 Years
65 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CREPS Auvergne Rhône-Alpes / Vichy
Bellerive-sur-Allier, Allier, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ID-RCB 2019-A02999-48
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.